8-K · ABBV

AbbVie files an 8-K on quarterly results

Filed with the SEC Oct 5, 2026, 4:07 PM ET · Posted Oct 25, 2026, 7:25 PM ET

AbbVie filed a Form 8-K on Oct 5, 2026 at 4:07 PM ET under Item 2.02 (Results of Operations and Financial Condition).

Under Item 2.02, the filing says: “Results for the quarter ended September 30, 2026 have not been finalized and are subject to our financial statement closing procedures.”

The filing attaches a press release as Exhibit 99.1.

Source

8-K filed Oct 5, 2026 (document)
Filing index on SEC EDGAR (all documents and exhibits)

AbbVie company file → · More AbbVie filings

Disclosures

Editor holdings in ABBV: The editor holds no position in AbbVie (ABBV). As of Oct 25, 2026.
Last updated: Oct 25, 2026

A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.